CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Yunkang Group Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Yunkang Group Ltd
No. 9 Yayingshi Road
Science City, Huangpu District
GUANGZHOU, GNG  China Ticker: 23252325
Business Summary
Yunkang Group Ltd is an investment holding company primarily engaged in the provision of diagnosis testing services. The Company’s service portfolio mainly includes three services. The diagnostic outsourcing services engages in the provision of diagnostic outsourcing services to hospitals, other medical institutions and public health institutions. The diagnostic testing services for medical institution alliances engages in assisting hospitals to establish on-site diagnostic centers through joint collaboration in main disease areas such as infectious diseases, reproductive health, genetic diseases and pathology, and the provision of comprehensive solutions including testing technologies, professional technicians and others to hospitals. The diagnostic testing services for non-medical institutions engages in the provision of personalized diagnostic testing, medical report consultation services and hospital referral services. The Company conducts its business in the domestic market.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202412/31/2023Yes----

Industries
SIC Code Description
8071 Medical laboratories
8099 Health and allied services, not elsewhere classified
6719 Offices of holding companies, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, Chief Executive Officer, Executive Director YongZhang 51 2/7/2021 7/20/2018
Chief Financial Officer, Joint Company Secretary YingjiaLin 43 2/7/2021 2/7/2021
Executive Vice President XuboWang 47 2/7/2021 2/7/2021
8 additional Officers and Directors records available in full report.

General Information
Number of Employees: 1,459 (As of 6/30/2024)
Outstanding Shares: 621,250,500 (As of 6/30/2024)
Stock Exchange: HKG


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024